You are on page 1of 2

INDUSTRIAL PROFILE

Serum Institute of India Ltd. has established it's self as the world's largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine manufactured by Serum Institute. In fact, our range of products have been used in 140 countries across the globe. Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines. The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Rabies vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world, in more than 140 countries are protected from birth onwards. Serum Institute of India have recently set up Serum Bio Pharma Park, India's first biotech Special Economic Zone (SEZ). The Park is adjoining Serum Institute's existing manufacturing unit and is a sector-specific SEZ meant for biotechnology and pharmaceutical products. The SEZ will allow Serum Institute of India to avail various tax benefits such as income tax, import duty on capital goods etc. This has encouraged a lot of foreign companies to partner with Serum Institute of India to avail and share these benefits. Serum Institute is recognized as a reliable source of High Quality vaccines and biologicals. Our products have been supplied to International Health Agencies like the WHO, UNICEF, PAHO and also to more than 140 countries across the globe. The high service standards have resulted in several acknowledgements and appreciation from International agencies and local governments and awards from Trade authorities. We are proud that our vaccines are being used in the National Immunization Program's of several countries. The MR vaccine is being used in catch-up and mop-up campaigns of several countries in their quest to control the incidence of measles and rubella. With the launch of the DTP-HB Combination Vaccines, Serum Institute will without doubt play a significant role in controlling the four dreaded diseases and bringing comfort to millions of children the world over, including the underprivileged.

The production facilities of Serum Institute have the best in terms of equipment and human resources; essential to ensure high quality vaccines. The manufacturing facilities conform to WHO current Good Manufacturing Practice (cGMP) requirements and are approved by WHO, Geneva. The unique large bioreactors for DTP group of vaccines have a huge batch size to produce millions of doses. The company also produces hundreds of millions of doses of the Measles, Mumps and Rubella group of vaccines annually. Serum Institute meets 100 % requirements for Measles vaccine of the Government of India and also the global requirements.. An interesting in-built mechanism of continuous improvement is by practicing the concept of Quality Circles. It empowers and encourages the employees at the grassroot level and at the same time brings about up gradation of quality of all fronts. The case studies of our Quality Circles have won many awards not only at State and national levels but also at the International Level. It goes without saying that Serum Institute's work ethic ensures that every safeguard is instituted, every norm of cGMP is scrupulously observed, and every procedure followed. Among the latest acquisitions is the state-of-the-art EDP system, which provides instant information on every aspect of production, from stocks, inventory, quantity of vaccines in the pipeline, Q.C. results of each batch, to sales, product dispatch and destinations. Quality is the buzzword. The assurance of quality starts from the Raw Material itself as soon as it enters the premises. It goes without saying that Qualification studies are mandatory for all equipment and all production and analytical procedures are validated. The stringency of control can be adjudged by the challenge that the production of Measles vaccine poses, as it is totally preservative free

You might also like